AMEDISYS INC (AMED) Stock Price, Quote, News and Overview
NASDAQ:AMED - Nasdaq - US0234361089 - Common Stock - Currency: USD
AMED Quote, Performance and Key Statistics
92
0 (0%)
The current stock price of AMED is 92 USD. In the past month the price decreased by -0.54%. In the past year, price decreased by -1.2%.
AMED Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.39 | 85.29B | ||
| CVS | CVS HEALTH CORP | 11.97 | 81.67B | ||
| LH | LABCORP HOLDINGS INC | 17.44 | 21.19B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.62 | 19.64B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 16.13 | 13.82B | ||
| DVA | DAVITA INC | 15.06 | 11.73B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 142.4 | 11.65B | ||
| HIMS | HIMS & HERS HEALTH INC | 75.33 | 8.89B | ||
| CHE | CHEMED CORP | 25.55 | 8.86B | ||
| OPCH | OPTION CARE HEALTH INC | 27.84 | 5.78B | ||
| CRVL | CORVEL CORP | 25.88 | 5.56B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.03B |
Related stock screener links
About AMED
Company Profile
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 19,000 full-time employees. The firm is engaged in providing care and support in the home. The company delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.
Company Info
AMEDISYS INC
3854 American Way Ste A, 5959 S Sherwood Forest Blvd
Baton Rouge LOUISIANA 70816 US
CEO: Paul B. Kusserow
Employees: 19000
Company Website: https://www.amedisys.com/
Investor Relations: http://investors.amedisys.com/
Phone: 12252922031
AMEDISYS INC / AMED FAQ
What is the stock price of AMEDISYS INC today?
The current stock price of AMED is 92 USD.
What is the ticker symbol for AMEDISYS INC stock?
The exchange symbol of AMEDISYS INC is AMED and it is listed on the Nasdaq exchange.
On which exchange is AMED stock listed?
AMED stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AMEDISYS INC stock?
16 analysts have analysed AMED and the average price target is 99.32 USD. This implies a price increase of 7.96% is expected in the next year compared to the current price of 92. Check the AMEDISYS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMEDISYS INC worth?
AMEDISYS INC (AMED) has a market capitalization of 3.01B USD. This makes AMED a Mid Cap stock.
How many employees does AMEDISYS INC have?
AMEDISYS INC (AMED) currently has 19000 employees.
What are the support and resistance levels for AMEDISYS INC (AMED) stock?
AMEDISYS INC (AMED) has a support level at 91.96 and a resistance level at 92.05. Check the full technical report for a detailed analysis of AMED support and resistance levels.
Is AMEDISYS INC (AMED) expected to grow?
The Revenue of AMEDISYS INC (AMED) is expected to grow by 5.26% in the next year. Check the estimates tab for more information on the AMED EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AMEDISYS INC (AMED) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMED, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMED, evaluating the profitability, health, valuation and growth aspects
- AMEDISYS INC (AMED) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMEDISYS INC (AMED) Sales and EPS estimates to see what analysts future expectations are.
- AMEDISYS INC (AMED) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMEDISYS INC (AMED) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMEDISYS INC (AMED) Stock Chart to make your own analysis
- AMEDISYS INC (AMED) Latest news and press-releases to stay up to date.
Does AMEDISYS INC (AMED) stock pay dividends?
AMED does not pay a dividend.
When does AMEDISYS INC (AMED) report earnings?
AMEDISYS INC (AMED) will report earnings on 2025-04-22, after the market close.
What is the Price/Earnings (PE) ratio of AMEDISYS INC (AMED)?
The PE ratio for AMEDISYS INC (AMED) is 21.35. This is based on the reported non-GAAP earnings per share of 4.31 and the current share price of 92 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMED.
What is the Short Interest ratio of AMEDISYS INC (AMED) stock?
The outstanding short interest for AMEDISYS INC (AMED) is 7.92% of its float. Check the ownership tab for more information on the AMED short interest.
AMED Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to AMED. When comparing the yearly performance of all stocks, AMED turns out to be only a medium performer in the overall market: it outperformed 65.51% of all stocks.
AMED Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AMED. While AMED has a great profitability rating, there are some minor concerns on its financial health.
AMED Financial Highlights
Over the last trailing twelve months AMED reported a non-GAAP Earnings per Share(EPS) of 4.31. The EPS increased by 0.47% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.84% | ||
| ROA | 2.02% | ||
| ROE | 3.81% | ||
| Debt/Equity | 0.3 |
AMED Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 54% to AMED. The Buy consensus is the average rating of analysts ratings from 16 analysts.
For the next year, analysts expect an EPS growth of 15.73% and a revenue growth 5.26% for AMED